MedPath
TGA Approval

BEVACIP bevacizumab 400 mg/16 mL concentrated solution for infusion vial (347291)

347291

BEVACIP bevacizumab 400 mg/16 mL concentrated solution for infusion vial

Cipla Australia Pty Ltd

November 2, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/752239e879f9d14f7027b1f364fdb149.pdf

Active Ingredients

Bevacizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BEVACIP bevacizumab 400 mg/16 mL concentrated solution for infusion vial (347291) - TGA 批准文号 | MedPath